Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 8:20 PM UTC
| NCT Number | NCT02732171 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | NA |
| Target Enrollment | 600 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | August 19, 2026 (1 week ago) |
As of August 31, 2026: Clinical trial NCT02732171 is currently recruiting participants. This na study for breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02732171 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02732171 was last updated 1 week ago (August 19, 2026). HelloStudys verifies this status automatically.